Data shows that Americans are relying on vaccines to get us through the pandemic
Data shows that Americans are relying on vaccines to get us through the pandemic.

Data shows that Americans are relying on vaccines to get us through the pandemic.
Data shows that Americans are relying on vaccines to get us through the pandemic.
Data shows that Americans are relying on vaccines to get us through the pandemic.
As we continue to combat the pandemic, America’s biopharmaceutical industry is working around the clock in unprecedented partnerships to manufacture COVID-19 vaccines, reaching billions of doses by the end of the year. Vaccination rates and willingness to receive a vaccine among Americans are also at a high, where half of all adults in the U.S. have received at least one dose of the COVID-19 vaccine.
Americans recognize that COVID-19 vaccines are integral to controlling the spread of coronavirus in the United States, and they appreciate the cautious approach to assessing vaccine safety.
Americans appreciate biopharmaceutical leadership in the research and development of COVID-19 vaccines.
With more Americans showing willingness to receive a coronavirus vaccine, Americans are counting on a strong U.S. biopharmaceutical industry to meet the growing demand. Now, more than ever, we need to ensure that we continue investing in this critical innovation ecosystem that supports our pandemic response. The industry is working nonstop to ramp up vaccine production while continuing to innovate around solutions to help end the pandemic.